It is a pharma private limited company based in Bangalore, Karnataka, India, established in 2018.
2018 | Bangalore, Karnataka, India | ActiveSarca Drug Private Limited, a active private limited company, was established on 13 August 2018 in Bangalore, Karnataka, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U51909KA2018PTC115460. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Its leadership includes Satyanarayana Yarakaraju (Director), Apsana Ibrahim Mujawar (Director), Narasaiahnapalya Puttanarasaiah Ramesh (Director). Past directors included Sripathy Shanbhog, Narasaiahnapalya Puttanarasaiah Ramesh. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at # 4/3, Ground Floor, 3Rd Cross, 3Rd Main Srs Road, Peenya New Extention, Bangalore, Karnataka, 560058.
U51909KA2018PTC115460
115460
13 August 2018
₹1.00 M
₹1.00 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Sarca Drug Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Satyanarayana Yarakaraju | Director | 13 Aug 2018 | Current |
| Apsana Ibrahim Mujawar | Director | 13 Aug 2018 | Current |
| Narasaiahnapalya Puttanarasaiah Ramesh | Director | 02 Jun 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 28 Feb 2025 | Past |
| Pramod Abcsdd | Additional Director | 26 Apr 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sarca Drug Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 114.99% increase. The company also saw a substantial improvement in profitability, with a 278.56% increase in profit. The company's net worth moved up by a moderate rise of 4.46%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Sarca Drug had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sarca Drug, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sarca Drug, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sarca Drug's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sarca Drug Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Sarca Drug Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was completed.
Narasaiahnapalya Puttanarasaiah Ramesh was appointed as a Director was appointed as a Director on 02 Jun 2023 & has been associated with this company since 2 years 6 months . was recorded as a recent event.
The activity Satyanarayana Yarakaraju was appointed as a Director was appointed as a Director on 13 Aug 2018 & has been associated with this company since 7 years 4 months . was completed.
Apsana Ibrahim Mujawar was appointed as a Director was appointed as a Director on 13 Aug 2018 & has been associated with this company since 7 years 4 months . was recorded as a recent event.
The activity Sarca Drug Private Limited was registered on 13 Aug 2018 with Roc Bangalore & aged 7 years 4 months as per MCA records. was completed.
The CIN of Sarca Drug Private Limited is U51909KA2018PTC115460.
Sarca Drug Private Limited is headquartered at # 4/3, Ground Floor, 3Rd Cross, 3Rd Main Srs Road, Peenya New Extention, Bangalore, Karnataka, 560058.
Sarca Drug Private Limited was incorporated on 13 August 2018.
The current directors of Sarca Drug Private Limited are
The primary industry of Sarca Drug Private Limited is Trade.
Sarca Drug Private Limited is unlisted.
The authorized capital of Sarca Drug Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX